Patent intelligence · US
US 7563777
Method to induce neovascular formation and tissue regeneration
Method to induce neovascular formation and tissue regeneration
Patent details — US 7563777
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jul 21, 2009
- Expiration
- Jul 16, 2029
- Claims
- 45
- CPC classes
- A61K, A61K38/1866, A61K48/0058, A61K48/0075
Quick answer
US 7563777 (Method to induce neovascular formation and tissue regeneration) is held by Fundacion Universitaria Dr. Rene G. Favaloro. Status: granted. Granted Jul 21, 2009. Expires Jul 16, 2029 (3 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Grant date
- Expiration
- Claims
- 45
- CPC classes
- A61K, A61K38/1866, A61K48/0058, A61K48/0075, A61K9/0019, A61K9/127
More from Fundacion Universitaria Dr. Rene G. Favaloro
Related pharmaceutical patents in our USPTO index.
-
US 12410153
Compounds, compositions and methods
granted -
US 12331107
Methods of treating pneumonia or respiratory failure associated with COVID-19 by administering an anti-LIGHT antibody
granted -
US 11939368
QTY Fc fusion receptor proteins
granted -
US 11898180
Compositions and methods for amino acid depletion therapy
granted -
US 11850243
Dihydropyridine compositions and methods for treating neurological disorders
granted -
US 11708406
Method of treating acute respiratory distress syndrome (ARDS) or acute lung injury (ALI) associate with COVID-19 by administering an anti-LIGHT antibody
granted -
US 11555060
QTY FC fusion water soluble receptor proteins
granted -
US 11479576
Nucleic acid prodrugs
granted
Frequently asked questions
What is US patent 7563777?
US 7563777 (Method to induce neovascular formation and tissue regeneration) is held by Fundacion Universitaria Dr. Rene G. Favaloro. Status: granted. Granted Jul 21, 2009. Expires Jul 16, 2029 (3 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 7563777?
Fundacion Universitaria Dr. Rene G. Favaloro is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 10 pharmaceutical patents for this assignee.
When does US 7563777 expire?
Our index shows an expiration date of Jul 16, 2029 (3 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.